NEW YORK (360Dx) – Australian molecular diagnostics firm Genetic Technologies today reported A$147,000 (US$117,000) in cash receipts from customers for its fiscal fourth quarter, down 25 percent from A$195,000 in fiscal Q3.

During the quarter, the firm also received A$260,000 for ongoing R&D expenditure as part of the Australian government's R&D tax incentive program, it said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.